Sunday, March 30, 2025 11:31:02 AM
Is any in-license technology currently tested in the combo trial? Did LP mention in the latest 10Q that the in-license technology is mainly about disrupting the growth of tumor blood vessel which can be done by VEGF inhibitor or t-cell engager PD-1/VEGF? Have you read the paper from Pawel Kalinski on a trial of GBM in which the in-license technology was tested? None of patients survived over three years. Did Roswell extend the completion of the following tumor-agnostic trial by two more years? What can you see from the following links?
https://clinicaltrials.gov/study/NCT04093323
I am only allowed one post a day. So I cannot reply you timely.
https://www.roswellpark.org/newsroom/201610-gov-cuomo-announces-landmark-roswell-park-study-bringing-cuban-lung-cancer-vaccine
Congressman Brian Higgins says, "Roswell Park Comprehensive Cancer Center is a special place, home to the best medical professionals and researchers fighting alongside those diagnosed with cancer each and every day. The new partnership between Roswell Park Comprehensive Cancer Center and CIM, supported by Governor Cuomo, has the potential to revolutionize lung cancer treatment – giving more people the care and hope they deeply deserve and need. This partnership shows what is possible when the talent and ambition of doctors and researchers is combined with a will to improve the world around us – and it’s happening right here in Buffalo.”
Roswell Park Secures More Than $15.4 Million in New Funding for Cancer Research
https://www.roswellpark.org/newsroom/201908-roswell-park-secures-more-154-million-new-funding-cancer-research
“The announcement today of more than $15 million in grants and awards to Roswell Park, including from the National Cancer Institute and National Institutes of Health, will help the cancer center continue the effort to make critical advancements in our understanding of the disease and develop new treatments to alleviate suffering and improve life quality,” says Congressman Brian Higgins.
https://www.roswellpark.org/newsroom/202007-research-grants-bring-more-29-million-supporting-work-roswell-park-scientists
“The current public health emergency provides an even greater perspective and appreciation for science, understanding of personal and community health, and hope for disease recovery and prevention,” says Congressman Brian Higgins. “Research grants are highly competitive. Roswell Park’s consistent success in earning grants is good for scientific advancement and for Western New York.”
Roswell Park's Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort
https://www.onclive.com/view/roswell-parks-dr-pawel-kalinski-to-lead-145m-ncifunded-immunotherapy-effort
"This five-year National Cancer Institute grant continues a long tradition of groundbreaking immunotherapy research at Roswell Park Comprehensive Cancer Center," says Congressman Brian Higgins. "The research the clinicians at Roswell are conducting represents the next generation of transformational care for cancer patients."
Roswell Park Teams Draw More Than $34 Million in Grants Supporting New Research
https://www.roswellpark.org/newsroom/202106-roswell-park-teams-draw-more-34-million-grants-supporting-new-research
“The scope and significance of the research being conducted right here at Roswell Park Comprehensive Cancer Center cannot be understated,” says Congressman Brian Higgins, co-chair of the U.S. House of Representatives Cancer Caucus. “The federal government invests in promising science and scientists. The magnitude of these grants represents a confidence in the work Roswell Park does and the hope Roswell Park’s discovery brings to families confronting COVID and cancer.”
Congressman Higgins Announces $1.5 Million in Federal Funding for Roswell Park Comprehensive Cancer Center
https://www.roswellpark.org/newsroom/202203-congressman-higgins-announces-15-million-federal-funding-roswell-park-comprehensive
Innovative Proposals From Roswell Park Teams Draw More Than $36 Million in Research Grants
https://www.roswellpark.org/newsroom/202201-innovative-proposals-roswell-park-teams-draw-more-36-million-research-grants
“Roswell Park has been a leader in groundbreaking cancer research for over 120 years, vastly improving treatment options and health outcomes for cancer patients in Western New York and around the world,” says Congressman Brian Higgins, Co-Chair of the Cancer Caucus in the U.S. House of Representatives. “In 2021, which marked the 50th anniversary of the National Cancer Act, Roswell Park acquired millions in competitive federal resources. Over $36 million received in prestigious grant awards, in the last six months alone, will allow Roswell to continue its historic work developing innovative, life-saving treatments that make a difference for patients young and old receiving care for a wide range of cancers.”
Governor Hochul Announces New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center in Buffalo
https://www.governor.ny.gov/news/governor-hochul-announces-new-yorks-first-cell-and-gene-therapy-hub-roswell-park-comprehensive
Representative Brian Higgins said, “Roswell Park has a long history and a bright future as a worldwide leader in the development of innovative cancer treatments and discoveries. This investment by Governor Hochul is more than a commitment to science. It is a commitment to all of the families in New York and beyond seeking hope and victory in the fight against cancer.”
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
